Antibiotic (International drug name) | N (%) |
---|---|
Monotherapy | |
Amoxicillin-clavulanate | 20 |
Piperacillin-tazobactam | 9 |
Third-generation cephalosporin | 8 |
Carbapenem | 6 |
Fluoroquinolone | 5 |
Amoxicillin | 4 |
Glycopeptide | 1 |
Other | 2 |
TOTAL | 55 (61.1) |
Combination therapy with 2 antibiotics | |
Piperacillin-tazobactam + fluoroquinolone | 6 |
Third-generation cephalosporin + other antibiotic | 6 |
Amoxicillin-clavulanate + Fluoroquinolone | 4 |
Third-generation cephalosporin + fluoroquinolone | 3 |
Carbapenem + other antibiotic | 3 |
Amoxicillin-clavulanate + other antibiotic | 3 |
Piperacillin-tazobactam + tigecyclin | 1 |
Piperacillin-tazobactam + antibiotic active against MRSAa | 2 |
Fluoroquinolone + rifampin | 1 |
TOTAL | 29 (32.2) |
Combination therapy with 3 or more antibiotics | |
Carbapenem + fluoroquinolone + aminoglycoside | 2 |
Pipera-tazobactam + fluoroquinolone + aminoglycoside | 1 |
Carbapenem + colistin + tigecyclin | 1 |
Pipera-tazobactam + fluoroquinolone + linezolide | 1 |
Carbapenem + colistin + glycopeptide | 1 |
TOTAL | 6 (6.7) |